Glycine

Glycine

SCHEMBL6853447

C=C.C=C.C=C.C=C.C=C.NCC(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 0.83
SLC6A9 P48067 1/20 0.83
OR51E2 Q9H255 1/20 0.83
GABRR1 P24046 4/20 0.47
LMNA P02545 5/20 0.42
TSHR P16473 4/20 0.42
THRB P10828 3/20 0.42
BLM P54132 2/20 0.42
KMT2A Q03164 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
GABRR3 A8MPY1 1/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
HDAC3 O15379 1/20 0.42
GABBR2 O75899 1/20 0.42
CYP1A2 P05177 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL6239942 1.00 GLRA1 (0.83) GLRA1SLC6A9OR51E2GABRR1LMNA
Glycine SCHEMBL5569329 1.00
Glycine SCHEMBL8585762 1.00 GLRA1 (0.83) GLRA1SLC6A9OR51E2GABRR1LMNA
Glycine SCHEMBL20295 1.00
Glycine SCHEMBL21879657 1.00 GLRA1 (0.83) GLRA1SLC6A9OR51E2GABRR1LMNA
Glycine SCHEMBL6511637 0.96
Glycine SCHEMBL27902160 0.96
Glycine SCHEMBL28163026 0.96
Glycine SCHEMBL27533089 0.96 GLRA1 (0.77) GLRA1SLC6A9OR51E2GABRR1LMNA
Glycine SCHEMBL27902232 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042348-A4 PLATELET DERIVED GROWTH FACTOR (PDGF) NUCLEIC ACID LIGAND COMPLEXES NEXSTAR PHARMACEUTICALS INC (US) 2004-07-07 EP disclosed
EP-1042348-A1 PLATELET DERIVED GROWTH FACTOR (PDGF) NUCLEIC ACID LIGAND COMPLEXES NeXstar Pharmaceuticals, Inc. (US) 2000-10-11 EP disclosed
WO-1999031119-A1 PLATELET DERIVED GROWTH FACTOR (PDGF) NUCLEIC ACID LIGAND COMPLEXES NEXSTAR PHARMACEUTICALS, INC. (US) 1999-06-24 WO disclosed
EP-0242806-A2 Charging adjuvants for liquid electrostatic developers E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-10-28 EP disclosed